South African multimillionaire Saltzmans gain $20 million in Dis-Chem
South African multimillionaire Saltzman family has gained $20 million as their Dis-Chem stake climbs to $588 million.
Dis-Chem Pharmacies
South African billionaire Saltzman family’s Dis-Chem stake tops $630 million
The Saltzman family’s Dis-Chem stake tops $630 million after steady JSE gains, signaling cautious investor confidence in pharmacy retail.
South African billionaire Saltzman family’s Dis-Chem posts $1.2 billion half-year revenue
Dis-Chem Pharmacies, backed by South Africa’s billionaire Saltzman family, posted $1.2 billion revenue in H1 2025, driven by retail and wholesale growth.
South Africa’s Saltzman-backed Dis-Chem opens 300th store in Mbombela
Dis-Chem, backed by South Africa’s Saltzman family, has opened its 300th store in Mbombela, expanding access to affordable primary healthcare.
South Africa’s Saltzman family stake in Dis-Chem rebounds to nearly $500 million
The Saltzman family’s stake in Dis-Chem has rebounded to nearly $500 million as shares rally on the Johannesburg Stock Exchange (JSE).
Saltzman family of South Africa sees $28.2 million drop in Dis-Chem stake
Dis-Chem founders lose $28 million as retail stock pressures hit Saltzman family’s holding on the Johannesburg Stock Exchange.
South Africa’s Ivan Saltzman transfers nearly $400 million in Dis-Chem shares to sons
The move involves 217 million shares held via Ivlyn Local Investment Holdings, an investment vehicle controlled by the Saltzman family.
Dis-Chem founder Ivan Saltzman restructures $377.7 million stake among heirs
Dis-Chem’s Ivan Saltzman restructures $377.7 million stake, transferring shares to heirs in a move reinforcing family control, succession, and executive alignment.
South Africa’s Saltzman family sees $28.6 million gain from Dis-Chem shares
This increase highlights the family's position as one of South Africa’s wealthiest.
South Africa’s Saltzman family gains $53.5 million from Dis-Chem shares
The Saltzman family’s Dis-Chem stake surged by $53.5 million, recovering earlier losses and reinforcing their position among South Africa’s richest investors amid renewed market confidence.
Saltzman family, one of South Africa’s richest, loses $43.95 million from Dis-Chem stake
This follows a previous loss between Feb. 7 and Mar. 10, when their stake dropped by $45.37 million, from $473.47 million to $428.09 million.
South Africa’s Saltzman family sees $45 million wipeout as Dis-Chem shares plunge
This latest drop comes after a $26.33 million loss earlier in the year.
Saltzman family gains $18.8 million as Dis-Chem shares climb
South Africa’s Saltzman family controls a 29.3 percent stake, equivalent to 302,066,319 ordinary shares in the Gauteng-based company.
South African billionaire Saltzman family Dis-Chem expands into insurance market with OneSpark acquisition
The Saltzman family, renowned South African billionaires and founders of Dis-Chem Pharmacies, has enhanced its integrated healthcare program through a binding Share Subscription Agreement (SSA) with OneSpark Proprietary Limited and OneSpark Holdings Inc., a Delaware-incorporated corporation.
South African billionaire Saltzman family’s Dis-Chem sees earnings top $73 million
The South African billionaire Saltzman family holds a 35.1 percent stake in the company, valued at R9.97 billion ($529.23 million).